loader image
Tuesday, May 28, 2024
76.3 F
McAllen
We Welcome your Press Release
- Advertisement -

DHR Health Institute of Research Launches Clinical Trial for Senseye

First-Ever Mobile Phone-Based Mental Health Diagnostic Device, Participants Needed

Translate to Spanish or other 102 languages!

Amy Ramirez, Nurse Practitioner and Clinical Researcher of the DHR Health Institute for Research and Development (left) and Vanessa Vale-Saenz, Vice President of the DHR Health Behavioral Hospital (right) look on with a prospective participant of the Senseye Clinical Study. The clinical trial evaluates the use of mobile phone-based eye-tracking software as a diagnostic tool for Post Traumatic Stress Disorder. The software tool, called Senseye, looks to revolutionize the way in which healthcare providers and patients diagnose and manage mental health conditions. Image courtesy of DHR Health
Amy Ramirez, Nurse Practitioner and Clinical Researcher of the DHR Health Institute for Research and Development (left) and Vanessa Vale-Saenz, Vice President of the DHR Health Behavioral Hospital (right) look on with a prospective participant of the Senseye Clinical Study. The clinical trial evaluates the use of mobile phone-based eye-tracking software as a diagnostic tool for Post Traumatic Stress Disorder. The software tool, called Senseye, looks to revolutionize the way in which healthcare providers and patients diagnose and manage mental health conditions. Image courtesy of DHR Health

Mega Doctor News

- Advertisement -

EDINBURG, Texas – The DHR Health Institute for Research and Development announced today its launch of a clinical trial that will evaluate the use of mobile phone-based eye-tracking software as a diagnostic tool for Post Traumatic Stress Disorder (PTSD).  The software, called Senseye, looks to revolutionize the way in which healthcare providers and patients diagnose and manage mental health conditions. PTSD affects many people due to different traumatic events in their lives. If Senseye meets FDA approval, it would be used to diagnose PTSD through eye movements, without the need to conduct extensive questioning about the patient’s traumatic experience. 

The DHR Health Institute of Research is actively seeking participants diagnosed with PTSD to join this groundbreaking trial. Participants will be paid to collaborate with a trained team, ensuring confidentiality of their information while contributing to the validation of this first-ever mental health diagnostic device for a cellphone. The trial commitment is over a three-month period. 

“This break-through innovative diagnostic tool (Senseye) will play a critical role in providing high quality care through its ability to accurately and objectively diagnose patients with Post Traumatic Stress Disorder, a psychiatric illness anticipated to be more prevalent in patients presenting to DHR Health since the hospital’s designation as a Level I Trauma Center. Rapid identification of these patients with PTSD will ultimately lead to more effective and focused treatment from both a pharmacological and non-pharmacological standpoint,” said Dr. Adrian Agapito, DHR Health Psychiatrist, Chief of Behavioral Medicine for DHR Health, and Medical Director of Outpatient Services for DHR Health. 

- Advertisement -

It is the theory of the study sponsor and device creator that the eye delivers an objective signal that can generate a valid diagnostic result as accurate as today’s gold standard psychiatric questionnaires. If so, eye signals could possibly become a replacement for surveys, providing more objective, measurable data to use in mental health diagnoses and, in the future, possibly even in the intervention and treatment stages. It is also hoped that the non-invasive, rapid biofeedback responses will lead to much faster results. In the case of this pilot study, heart rate and eye movement, including pupil dilation and frequency of eye change, are monitored via video in response to images that elicit emotional responses.

Currently, the DHR Health Institute of Research and Development is looking for PTSD patients, over the age of 18, who are willing to share information privately with a professionally-trained team. The team will privately use any volunteer’s information anonymously to test the Senseye device and gather the data needed for FDA approval. If successful, the device would be available and accessible to PTSD patients nationwide.

For those interested in participating in the Senseye clinical trial, please call the DHR Health Institute of Research and Development at (956) 362-2390.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Primary Pollutant: A Rising Concern for Air Quality in South Texas

This high concentration of fine particulate matter poses significant health risks to the population.

$17 Million Grant for Rural Hospitals Announced

HHSC provides grant funding and administers programs for rural hospitals in alignment with the Rural Hospital Services Strategic Plan, which aims to ensure rural Texans have access to hospital services.

DHR Health Hosts “Mammos for Moms” Mammogram Screening Special Throughout May

This screening mammogram will provide digital 3D (three dimensional) tomography imaging, with radiologist interpretation, for only $99. A referral from a primary care physician or gynecologist is required.

TMA Elects Houston, North Texas, Central Texas, Panhandle Physicians to Board 

Physicians from across the state conducted the elections on Saturday during TexMed 2024, TMA’s annual conference, in Dallas.
- Advertisement -
×